Neuro News Roundup: Treating MS & Epilepsy

Slideshow

New research covers treating MS early, identifying those at risk for AED-induced psychosis, & selecting a drug for epilepsy patients with migraines.

Early treatment of new onset multiple sclerosis (MS) with interferon β-1b therapy leads to clinical benefits. Several risk factors may help identify epilepsy patients who may be at higher risk for psychosis due to their antiepileptic drug treatment. Topiramate is an appropriate treatment for epilepsy patients with comorbid migraine.

Related Videos
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
Enrique Alvarez, MD, PhD
Claude Steriade, MD, CM
Jiwon Oh, MD, PhD
Carly Wender, PhD
Fred Lado, MD, PhD
Patricia C. Dugan, MD
© 2024 MJH Life Sciences

All rights reserved.